Login/Sign Up
Sucrobind 500 mg Chewable Tablet 6's belongs to the class of medications called mineral supplements indicated for controlling serum phosphorus levels in adult chronic kidney disease patients on haemodialysis or peritoneal dialysis.
Sucrobind 500 mg Chewable Tablet 6's contains 'sucroferric oxyhydroxide'. It helps to lower phosphate levels in the blood and prevents complications caused by high phosphate levels in the blood, especially in dialysis patients who are unable to eliminate excess phosphate levels.
Sucrobind 500 mg Chewable Tablet 6's should be taken as prescribed by your doctor. Sucrobind 500 mg Chewable Tablet 6's can cause side effects such as diarrhoea, nausea, vomiting, constipation, and indigestion in some cases. These side effects are not universal and vary from person to person. Please consult your doctor if you experience any of the side effects persistently.
Do not take Sucrobind 500 mg Chewable Tablet 6's if you are allergic to any of the contents, if you have/had haemochromatosis, or iron overload disorder. Before using this medication, inform your doctor of any medical issues you may have. Consult your doctor if you are pregnant or breastfeeding. The safety and efficacy of Sucrobind 500 mg Chewable Tablet 6's in children blow 2years have not been established.
Sucrobind 500 mg Chewable Tablet 6's contains sucroferric oxyhydroxide indicated for controlling serum phosphorus levels in adult chronic kidney disease patients on haemodialysis or peritoneal dialysis. Sucrobind 500 mg Chewable Tablet 6's helps to lower phosphate levels in the blood and prevents issues caused by high phosphate levels in the blood, especially in dialysis patients who are unable to get rid of excess phosphate levels.
Do not take Sucrobind 500 mg Chewable Tablet 6's if you are allergic to any of the contents, if you have/had haemochromatosis, or iron overload disorder. Notify your doctor if you have/had inflammation of the peritoneum, stomach/intestinal surgery, stomach and/or liver problems. Before using this medication, tell your doctor about any health complications you have. Inform your doctor if you are taking any other medications. Consult your doctor if you are pregnant or nursing.
Drug-Drug Interactions: Sucrobind 500 mg Chewable Tablet 6's may interact with certain medications used to treat bladder cancer (erdafitinib), antibiotic (doxycycline), hormone (levothyroxine).
Drug-Food Interactions: Limit or quit the consumption of alcohol.
Drug-Disease Interactions: Sucrobind 500 mg Chewable Tablet 6's may interact with disease conditions like hemochromatosis (extra iron builds up in the body).
Hyperphosphatemia: Hyperphosphatemia is an electrolyte disorder characterised by an elevated phosphate level in the blood. Healthy kidneys balance phosphorus levels in the body by removing excess phosphorus from the blood. If you have kidney disease, your kidneys may not be able to eliminate excess phosphorus. It has the potential to be extremely harmful to one's health. High phosphorus levels do not always cause symptoms. Extra phosphorus in the blood can eliminate calcium from the bones and other parts of the body, resulting in low calcium (hypocalcemia).
About Sucrobind 500 mg Chewable Tablet 6's
Sucrobind 500 mg Chewable Tablet 6's belongs to the class of medications called mineral supplements indicated for controlling serum phosphorus levels in adult chronic kidney disease patients on haemodialysis or peritoneal dialysis.
Sucrobind 500 mg Chewable Tablet 6's contains 'sucroferric oxyhydroxide'. It helps to lower phosphate levels in the blood and prevents complications caused by high phosphate levels in the blood, especially in dialysis patients who are unable to eliminate excess phosphate levels.
Sucrobind 500 mg Chewable Tablet 6's should be taken as prescribed by your doctor. Sucrobind 500 mg Chewable Tablet 6's can cause side effects such as diarrhoea, nausea, vomiting, constipation, and indigestion in some cases. These side effects are not universal and vary from person to person. Please consult your doctor if you experience any of the side effects persistently.
Do not take Sucrobind 500 mg Chewable Tablet 6's if you are allergic to any of the contents, if you have/had haemochromatosis, or iron overload disorder. Before using this medication, inform your doctor of any medical issues you may have. Consult your doctor if you are pregnant or breastfeeding. The safety and efficacy of Sucrobind 500 mg Chewable Tablet 6's in children blow 2years have not been established.
Sucrobind 500 mg Chewable Tablet 6's
₹302.4*
MRP ₹336
10% off
₹285.6*
MRP ₹336
15% CB
₹50.4 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Country of origin
Alcohol
Caution
It is not recommended to drink alcohol while taking Sucrobind 500 mg Chewable Tablet 6's because it may cause unpleasant side effects.
Pregnancy
Caution
Please seek advice from a healthcare professional. There are no adequate and well-controlled studies on pregnant women. Your doctor will prescribe only if the benefits outweigh the risks.
Breast Feeding
Caution
Consult your healthcare professional as there is no substantial research yet on the use of Sucrobind 500 mg Chewable Tablet 6's in breastfeeding/nursing mothers.
Driving
Caution
It is unknown whether Sucrobind 500 mg Chewable Tablet 6's affects driving ability. Do not drive or operate machinery if you have any symptoms that impair your ability to concentrate or react.
Liver
Caution
Consult your doctor if you have liver problems. Your doctor will prescribe only if the benefits outweigh the risks.
Kidney
Caution
Consult your doctor if you have kidney problems.
Children
Caution
The safety and efficacy of Sucrobind 500 mg Chewable Tablet 6's in children below 2years have not been established.
Uses of Sucrobind 500 mg Chewable Tablet 6's
Medicinal Benefits
Sucrobind 500 mg Chewable Tablet 6's contains sucroferric oxyhydroxide indicated for controlling serum phosphorus levels in adult chronic kidney disease patients on haemodialysis or peritoneal dialysis. Sucrobind 500 mg Chewable Tablet 6's helps to lower phosphate levels in the blood and prevents issues caused by high phosphate levels in the blood, especially in dialysis patients who are unable to get rid of excess phosphate levels.
Side Effects of Sucrobind 500 mg Chewable Tablet 6's
Directions for Use
Storage
Drug Warnings
Do not take Sucrobind 500 mg Chewable Tablet 6's if you are allergic to any of the contents, if you have/had haemochromatosis, or iron overload disorder. Notify your doctor if you have/had inflammation of the peritoneum, stomach/intestinal surgery, stomach and/or liver problems. Before using this medication, tell your doctor about any health complications you have. Inform your doctor if you are taking any other medications. Consult your doctor if you are pregnant or nursing.
Therapeutic Class
Drug-Drug Interactions Checker List
Diet & Lifestyle Advise
Habit Forming
Special Advise
Disease/Condition Glossary
Hyperphosphatemia: Hyperphosphatemia is an electrolyte disorder characterised by an elevated phosphate level in the blood. Healthy kidneys balance phosphorus levels in the body by removing excess phosphorus from the blood. If you have kidney disease, your kidneys may not be able to eliminate excess phosphorus. It has the potential to be extremely harmful to one's health. High phosphorus levels do not always cause symptoms. Extra phosphorus in the blood can eliminate calcium from the bones and other parts of the body, resulting in low calcium (hypocalcemia).